Alexander Macrae

Alexander Macrae

Chief Executive Officer at SANGAMO THERAPEUTICS, INC.

Net worth: 304 584 $ as of 30/05/2026

63 year
Health Technology
Consumer Services

Profile

Alexander D.
Macrae
is President, Chief Executive Officer & Director at Sangamo Therapeutics, Inc. since 2016.
Dr. Macrae is a Member of The Royal College of Physicians.
Former roles include Independent Non-Executive Director at 4D Pharma Plc from 2019 to 2023, Global Medical Officer at Takeda Pharmaceuticals U.S.A., Inc. from 2012 to 2016, and Senior VP-Emerging Markets Research & Development at GlaxoSmithKline LLC from 2009 to 2012.
Education includes an undergraduate degree from the University of Glasgow in 1986 and a doctorate from King's College, Cambridge in 1994.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
24/05/2026 1,397,174 ( 0.34% ) 304 584 $ 30/05/2026

Alexander Macrae active positions

CompaniesPositionStart
SANGAMO THERAPEUTICS, INC. Chief Executive Officer 31/05/2016
Corporate Officer/Principal -

Former positions of Alexander Macrae

CompaniesPositionEnd
4D PHARMA PLC Director/Board Member 14/03/2023
Chief Tech/Sci/R&D Officer 29/02/2016
Corporate Officer/Principal 31/12/2011
See the detail of Alexander Macrae's experience

Training of Alexander Macrae

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Alexander Macrae